[1] FREDDIE B,JACQUES F,ISABELLE S,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2018,68(6):394-424. [2] BYERS L A,RUDIN C M.Small cell lung cancer: where do we go from here? [J].Cancer,2015,121(5):664-672. [3] NELSON W J,NUSSE R.Convergence of Wnt,beta-catenin,and cadherin pathways [J].Science,2004,303(5663):1483-1487. [4] ZEBISCH M,JACKSON V A,ZHAO Y G,et al.Structure of the dual-mode Wnt regulator kremen1 and insight into ternary complex formation with LRP6 and dickkopf [J].Structure,2016,24(9):1599-1605. [5] KRUPNIK V E,SHARP J D,JIANG C,et al.Functional and structural diversity of the human Dickkopf gene family[J].Gene,1999,238(2):301-313. [6] YAMABUKI T,TAKANO A,HAYAMA S,et al.Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas [J].Cancer Res,2007,67(6):2517-2525. [7] SATO N,YAMABUKI T,TAKANO A,et al.Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy [J].Cancer Res,2010,70(13):5326-5336. [8] WANG K,ZHANG Y Z,LI X F,et al.Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism [J].J Biol Chem,2008,283(34):23371-23375. [9] VANDOOREN J,VAN DEN STEEN P E,OPDENAKKER G .Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9): the next decade [J].Crit Rev Biochem Mol Biol,2013,48(3):222-272. [10] VAN DEN STEEN P E,DUBOIS B,NELISSEN I,et al.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9) [J].Crit Rev Biochem Mol Biol,2002,37(6):375-536. [11] AGRAWAL A,ROMERO-PEREZ D,JACOBSEN J A,et al.Zinc-binding groups modulate selective inhibition of MMPs [J].Chem Med Chem,2008,3(5):812-820. [12] HOU H L,ZHANG G J,WANG H Y,et al.High matrix metalloproteinase-9 expression induces angiogenesis and basement membrane degradation in stroke-prone spontaneously hypertensive rats after cerebral infarction [J].Neural Regen Res,2014,9(11):1154-1162. [13] BLANCO-PRIETO S,BARCIA-CASTRO L,PAEZ DELA CADENA M,et al.Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis [J].BMC Cancer,2017,17(1):823. [14] GOLUBNITSCHAJA O,YEGHIAZARYAN K,ABRAHAM J A,et al.Breast cancer risk assessment: a non-invasive multiparametric approach to stratify patients by MMP-9 serum activity and RhoA expression patterns in circulating leucocytes [J].Amino Acids,2017,49(2): 273-281. [15] YEH H C,LIN S M,CHEN M F,et al.Evaluation of serum matrix metalloproteinase (MMP)-9 to MMP-2 ratio as a biomarker in hepatocellular carcinoma [J].Hepatogastroenterology,2010,57(97):98-102. [16] YAO L L,ZHANG D F,ZHAO X L,et al.Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype [J].J Cell Mol Med,2016,20(9): 1673-1685. [17] MANIOTIS A J,FOLBERG R,HESS A,et al.Vascular Channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry [J].Am J Pathol,1999,155(3):739-752. [18] LIU T J,SUN B C,ZHAO X L,et al.CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer [J].Oncogene,2013,32(5):544-553. |